Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Dorchy

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
Clinical Pediatrics|December 1, 1979
EEG abnormalities in diabetic children: influence of hypoglycemia and vascular complicationsD Haumont, H Dorchy, S Pelc
Diabete & Metabolisme|July 1, 1988
Normalization of complement activation and consumption in diabetic children and adolescents after switch-over from porcine to semisynthetic human insulinH Dorchy, J Duchateau, D D'Hooge
Revue Medicale De Bruxelles|August 5, 2016
[Maturity onset diabetes of the young: just think about it]A Messaaoui, S Tenoutasse, H Dorchy
Acta Paediatrica Scandinavica|May 1, 1985
Subclinical thyroid hormone abnormalities in type I diabetic children and adolescents. Relationship to metabolic controlH Dorchy, P Bourdoux, B Lemiere
Diabetes & Metabolism|January 20, 2016
Difficulties describing feelings to others still predicts glycaemic control up to 24 months later in children with type 1 diabetesM Housiaux, O Luminet, H Dorchy
Diabete & Metabolisme|July 1, 1992
Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitroJ Duchateau, H Schreyen, H Dorchy
Archives of Disease in Childhood|April 1, 1977
Standardization of insulin preparations and syringesH Dorchy, C Ernould, H Loeb
Presse Medicale (Paris, France : 1983)|February 10, 1996
[Erythrocyte and plasma antioxidant activity in diabetes mellitus type I]J Ndahimana, H Dorchy, F Vertongen
Diabetes & Metabolism|September 12, 2008
Does family cohesiveness and parental alexithymia predict glycaemic control in children and adolescents with diabetes?J Meunier, H Dorchy, O Luminet
Atherosclerosis|August 7, 1998
Serum antioxidant status and oxidized LDL in well-controlled young type 1 diabetic patients with and without subclinical complicationsD Willems, H Dorchy, D Dufrasne
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Clinical Pediatrics|December 1, 1979
EEG abnormalities in diabetic children: influence of hypoglycemia and vascular complicationsD Haumont, H Dorchy, S Pelc
Diabete & Metabolisme|July 1, 1988
Normalization of complement activation and consumption in diabetic children and adolescents after switch-over from porcine to semisynthetic human insulinH Dorchy, J Duchateau, D D'Hooge
Revue Medicale De Bruxelles|August 5, 2016
[Maturity onset diabetes of the young: just think about it]A Messaaoui, S Tenoutasse, H Dorchy
Acta Paediatrica Scandinavica|May 1, 1985
Subclinical thyroid hormone abnormalities in type I diabetic children and adolescents. Relationship to metabolic controlH Dorchy, P Bourdoux, B Lemiere
Diabetes & Metabolism|January 20, 2016
Difficulties describing feelings to others still predicts glycaemic control up to 24 months later in children with type 1 diabetesM Housiaux, O Luminet, H Dorchy
Diabete & Metabolisme|July 1, 1992
Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitroJ Duchateau, H Schreyen, H Dorchy
Archives of Disease in Childhood|April 1, 1977
Standardization of insulin preparations and syringesH Dorchy, C Ernould, H Loeb
Presse Medicale (Paris, France : 1983)|February 10, 1996
[Erythrocyte and plasma antioxidant activity in diabetes mellitus type I]J Ndahimana, H Dorchy, F Vertongen
Diabetes & Metabolism|September 12, 2008
Does family cohesiveness and parental alexithymia predict glycaemic control in children and adolescents with diabetes?J Meunier, H Dorchy, O Luminet
Atherosclerosis|August 7, 1998
Serum antioxidant status and oxidized LDL in well-controlled young type 1 diabetic patients with and without subclinical complicationsD Willems, H Dorchy, D Dufrasne
Pageof 17